The human cytokine response to Leishmania major early after exposure to the parasite in vitro

Journal of Parasitology

Volumn 90, Issue 3, 2004, Pages 557-563

  Rogers, Kathleen A ^a,b   Titus, Richard G ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA;

FLAGELLATE; LEISHMANIASIS; PARASITE; PROTEIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD CULTURE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE EXACERBATION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PARASITE; PHAGOCYTE; TH1 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MONONUCLEAR CELL; MOUSE; PARASITOLOGY;

LEISHMANIA MAJOR; MURINAE; PROTOZOA;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-5; LEISHMANIA MAJOR; LEUKOCYTES, MONONUCLEAR; MICE; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 3142759928     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-3317     Document Type: Article

References (57)

1. AJDARY, S., M. H. ALIMOHAMMADIAN, M. B. ESLAMI, K. KEMP, AND A. KHARAZMI. 2000. Comparison of the immune profile of non-healing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection. Infection and Immunity 68: 1760-1764.
2. AKUFFO, H., A. ALEXIS, L. EIDSMO, A. SAED, S. NYLEN, AND K. MAASHO. 1999. Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen stimulated blood donor cells. Clinical and Experimental Immunology 117: 529-534.
3. -, AND S. F. BRITTON. 1992. Contribution of non-Leishniania specific immunity to resistance to Leishmania infection in humans. Clinical and Experimental Immunology 87: 58-64.
4. -, K. MAASHO, M. BLOSTEDT, B. HOJEBERO, S. BRITTON, AND M. BAKHIET. 1997. Leishmania aelliiopica derived from diffuse cutaneous leishmaniasis patients preferentially induce mRNA for IL-10 while those from localized leishmaniasis patients induce IFN-γ. Journal of Infectious Diseases 175: 737-741.
5. BACELLAR, O., A. D'OLIVEIRA, S. JERONIMO, AND E. M. CARVALHO. 2000. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12: 1228-1231.
6. BARRAL, A., M. TEIXEIRA, P. REIS, V. VINHAS, J. COSTA, H. LESSA, A. L. BITTENCOURT, S. REED, E. M. CARVALHO, AND M. BARRAL-NETTO. 1995. Transforming growth factor-beta in human cutaneous leishmaniasis. American Journal of Pathology 147: 947-954.
7. BELKAID, Y., C. A. PICCIRILLO, S. MENDEZ, E. M. SHEVACH, AND D. L. SACKS. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
8. BOTTREL, R. L. A., W. O. DUTRA, F. A. MARTINS, B. HOJEBERG, S. BRITTON, AND M. BAKHIET. 2001. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infection and Immunity 69: 3232-3239.
9. BRADLEY, L. M., D. K. DALTON, AND M. CROFT. 1996. A direct role for IFN-γ in regulation of Th1 cell development. Journal of Immunology 157: 1350-1358.
10. BRETSCHER, P. A., G. WEI, J. N. MENON, AND H. BIELEFELDT-OHMANN. 1992. Establishment of stable cell mediated immunity makes susceptible mice resistant to Leishmania major. Science 257: 539-541.
11. BRODSKYN, C., A. BARRAL, V. BOAVENTURA, E. CARVALHO, AND M. BARRAL-NETTO. 1997. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. Immunology 159: 4467-4473.
12. -) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro. Clinical and Experimental Immunology 119: 299-304.
13. CARVALHO, E. M., O. BACELLAR, C. BROWNELL, T. REGIS, R. L. COFFMAN, AND S. G. REED. 1994. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. Journal of Immunology 152: 5949-5956.
14. -, A. BARRAL, D. PEDRAL-SAMPAIO, M. BARRAL-NETTO, R. BADARO, H. ROCHA, AND W. D. JOHNSON JR. 1992. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. Journal of Infectious Diseases 165: 535-540.
15. CHATELAIN, R., S. MAUZE, AND R. L. COFFMAN. 1999. Experimental Leishmania major infection in mice: Role of IL-10. Parasite Immunology 21: 211-218.
16. DOHERTY, M. T., AND R. L. COFFMAN. 1996. Leishmania major: Effect of infectious dose on T cell subset development in BALB/c mice. Experimental Parasitology 84: 124-135.
17. FOUCRAS, G., J. D. COUDERT, C. COUREAU, AND J. C. GUERRY. 2000. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine and TGF-beta producing cells in the absence of CD8 T cell activation. Journal of Immunology 165: 4994-5003.
18. GANTT, K. R., S. SCHULTZ-CHERRY, N. RODRIGUEZ, S. M. JERONIMO, E. T. NASCIMENTO, T. L. GOLDMAN, T. J. RECKER, M. A. MILLER, AND M. E. WILSON. 2003. Activation of TGF-beta by Leishmania chagasi: Importance for parasite survival in macrophages. Journal of Immunology 170: 2613-2620.
19. GHALIB, H. W., M. R. PIUVEZAM, Y. A. W. SKEIKY, M. SIDDIG, F. A. HASHIM, A. M. EL-HASSAN, D. M. RUSSO, AND S. G. REED. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. Journal of Clinical Investigation 92: 324-329.
20. -, J. A. WHITTLE, M. KUBIN, F. A. HASHIM, A. M. EL-HASSAN, K. H. GRABSTEIN, G. TRINCHIERI, AND S. G. REED. 1995. IL-12 enhances Th1-type responses in human Leishmania donovani infections. Journal of Immunology 154: 4623-4629.
21. GOLDROSEN, M. H., P. J. GANNON, M. LUTZ, AND E. D. HOLYOKE. 1977. Isolation of human peripheral blood lymphocytes: Modification of double discontinuous density gradient of Ficoll-Hypaque. Journal of Immunological Methods 14: 15-17.
22. GROUX, H., F. COTTREZ, M. ROULEAU, S. MAUZE, S. ANTONENKO, S. HURST, T. MCNEIL, M. BIGLER, M. G. RONCAROLO, AND R. L. COFFMAN 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. Journal of Immunology 162: 1723-1729.
23. HANDMAN, E. 2001. Leishmaniasis: Current status of vaccine development. Clinical Microbiology Reviews 14: 229-243.
24. HERWALDT, B. L. 1999. Leishmaniasis. Lancet 354: 1191-1199.
25. HIMMELRICH, H., P. LAUNOIS, I. MAILLARD, T. BIEDERMANN, F. TACCHINI-COTTIER, R. M. LOCKSLEY, M. ROCKEN, AND J. A. LOUIS. 2000. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. Journal of Immunology 164: 4819-4825.
26. HSIEH, C. S., S. E. MACATONIA, C. S. TRIPP, S. F. WOLF, A. O'GARRA, AND K. M. MURPHY. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549.
27. JANEWAY, C. A., P. TRAVERS, M. WALPORT, AND M. SHLOMCHIK. 2001. Immunobiology, 5th ed. Garland Publishing, New York, 732 p.
28. KEMP, M. 1997. Regulator and effector functions of T-cell subsets on human Leishmania infections. APMIS 105(68): 5-33.
29. KEMP, M., A. S. HEY, J. A. KURTZHALS, C. B. CHRISTENSEN, A. GAAFAR, M. D. MUSTAFA, A. A. KORDOFANI, A. ISMAIL, A. KHARAZMI, AND T. G. THEANDER. 1994. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clinical and Experimental Immunology 96: 410-415.
30. KEMP, K., T. G. THEANDER, L. HVIID, A. GARFAR, A. KHARAZMI, AND M. KEMP. 1999. Interferon-γ and tumor necrosis factor-α producing cells in humans who are immune to cutaneous leishmaniasis. Scandinavian Journal of Immunology 49: 655-659.
31. KONYA, J., AND J. DILLNER. 2001. Immunity to oncogenic human papillomaviruses. Advances in Cancer Research 82: 205-238.
32. LAUNOIS, P., F. TACCHINI-COTTIER, C. PARRA-LOPEZ, AND J. A. LOUIS. 1998. Cytokines in parasitic diseases: The example of cutaneous leishmaniasis. International Reviews of Immunology 17: 157-180.
33. MELBY, P. C., F. ANDRADE-NARVAEZ, B. J. DARNELL, AND G. VALENCIA-PACHECO. 1996. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. FEMS Immunology and Medical Microbiology 15: 101-107.
34. MELBY, P. C., F. J. ANDRADE-NARVAEZ, B. J. DARNELL, G. VALENCIA-PACHECO, V. V. TRYON, AND A. PALOMO-CETINA. 1994. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infection and Immunity 62: 837-842.
35. MEMON, J. N., AND P. A. BRETSCHER. 1998. Parasite dose determines the Th1-Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. European Journal of Immunology 28: 4020-4028.
36. MORRIS, S. C., K. B. MADDEN, J. J. ADAMOVICZ, W. C. CAUSE, B. R. HUBBARD, M. K. GATELY, AND F. D. FINKELMAN. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. Journal of Immunology 152: 1047-1056.
37. MOSMANN, T. R., AND R. L. COFFMAN. 1989. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annual Reviews of Immunology 7: 145.
38. MURRAY, H. W., B. Y. RUBIN, AND C. D. ROTHERMEL. 1983. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. Journal of Clinical Investigation 72: 1506-1510.
39. NELSON, B. J., P. RALPH, S. J. GREEN, AND C. A. NACY. 1991. Differential susceptibility of activated macrophages cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. Journal of Immunology 146: 1849-1857.
40. NYLEN, S., U. MORTBERG, D. KOVALENKO, I. SATTI, K. ENGSTROM, M. BAKHIET, AND H. AKUFFO. 2001. Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors. Clinical and Experimental Immunology 124: 43-53.
41. PIRMEZ, C., K. YAMAMURA, K. UYEMURA, M. PAES-OLIVEIRA, F. CONCEICAO-SILVA, AND R. L. MOULIN. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. Journal of Clinical Investigations 91: 1390-1395.
42. POMPEU, M. M. L., C. BRODSKYN, M. J. TEIXEIRA, J. CLARENCIO, J. VAN WEYENBERG, I. C. B. COELHO, S. A. CARDOSO, A. BARRAL, AND M. BARRAL-NETTO. 2001. Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infection and Immunity 69: 7453-7460.
43. RODRIGUES V. JR., J. Santanta da Silva, and A. Campos-Neto. 1998. Transforming growth factor β and immunosuppression on experimental visceral leishmaniasis. Infection and Immunity 66: 1233-1236.
44. RUSSO, D. M., P. CHAKRABARTI, AND J. M. BURNS JR. 1998. Naive human T cells develop into Th1 or Th0 effectors and exhibit cytotoxicity early after stimulation with Leishmania-infected macrophages. Journal of Infectious Diseases 177: 1345-1351.
45. -, -, AND A. Y. HIGGINS. 1999. Leishmania: Naïve human T cells sensitized with promastigote antigen and IL-12 develop into potent Th1 and CD8+ cytotoxic effectors. Experimental Parasitology 93: 161-170.
46. SOARES, M. B. P., J. R. DAVID, AND R. G. TITUS. 1997. An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infection and Immunity 65: 2837-2845.
47. SOLBACH, W., AND T. LASKAY. 2000. The host response to Leishmania infection. Advances in Immunology 74: 275-317.
48. SPELBERG, B., AND J. E. EDWARDS JR. 2001. Type 1/Type 2 immunity in infectious diseases. Clinical and Infectious Diseases 32: 76-102.
49. SUNDAR, S., S. G. REED, S. SHARMA, A. MEHROTRA, AND H. W. MURRAY. 1997. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene 56: 522-525.
50. SWINGENBERGER, K., G. HARMS, AND C. PEDEROSA. 1990. Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-gamma production. Clinical and Immunological Immunopathology 57: 242-249.
51. TITUS, R. G., A. KELSO, AND J. A. LOUIS. 1984. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clinical and Experimental Immunology 55: 157-165.
52. -, C. M. THEODOS, A. H. SHANKAR, AND L. R. HALL. 1994. Interactions between Leishmania major and macrophages. Immunological Series 60: 437-459.
53. TRINCHIERI, G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annual Reviews in Immunology 13: 251-276.
54. WEINSTOCK, C., J. KNOBLOCK, W. SCHULTHEIS, AND H. NORTHOFF. 1997. Impaired production of cytokines in a case of human leishmaniasis. Clinical Infectious Diseases 25: 1334-1339.
55. WILSON, M. E., R. M. YOUNG, B. L. DAVIDSON, K. A. MENTE, AND S. E. MCGOWAN. 1998. The importance of TGF-β in murine visceral leishmaniasis. Journal of Immunology 161: 6148-6155.
56. YANG, J., T. L. MURPHY, W. OUYANG, AND K. M. MURPHY. 1999. Induction of interferon-γ production in Th1 CD4+ T cells: Evidence for two distinct pathways for promoter activation. European Journal of Immunology 29: 548-555.
57. YOUNG, J. L., A. DASER, AND P. C. L. BEVERLEY. 1995. In vitro proliferative responses of human peripheral blood mononuclear cells to non-recall antigens. Journal of Immunological Methods 182: 177-184.